Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia

被引：5

作者：

Cafforio, Luciana ^{[1
]}

Raponi, Sara ^{[1
]}

Cappelli, Luca Vincenzo ^{[1
]}

Ilari, Caterina ^{[1
]}

Soscia, Roberta ^{[1
]}

De Propris, Maria Stefania ^{[1
]}

Mariglia, Paola ^{[1
]}

Rigolin, Gian Matteo ^{[2
]}

Bardi, Antonella ^{[2
]}

Peragine, Nadia

Piciocchi, Alfonso ^{[3
]}

Arena, Valentina ^{[3
]}

Mauro, Francesca Romana ^{[1
]}

Cuneo, Antonio

Guarini, Anna ^{[4
]}

Foa, Robin ^{[1
]}

Del Giudice, Ilaria ^{[1
]}

机构：

[1] Sapienza Univ, Hematol Sect, Dept Translat & Precis Med, Rome, Italy

[2] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Dept Med Sci, Hematol Sect, Ferrara, Italy

[3] GIMEMA Fdn, GIMEMA Data Ctr, Rome, Italy

[4] Sapienza Univ, Dept Mol Med, Rome, Italy

来源：

HAEMATOLOGICA | 2022年 / 107卷 / 01期

关键词：

CLINICAL IMPACT; RESISTANCE; MUTATIONS;

D O I：

10.3324/haematol.2020.263715

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：334 / 337

页数：4

共 50 条

[41] Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis
Liu, Yen-Chun
Margolskee, Elizabeth
Allan, John N.
Mathew, Susan
Bhavsar, Erica
Casano, Joseph
Orazi, Attilio
Furman, Richard R.
Geyer, Julia T.
MODERN PATHOLOGY, 2020, 33 (03) : 344 - 353
[42] Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Rossi, Davide
Khiabanian, Hossein
Spina, Valeria
Ciardullo, Carmela
Bruscaggin, Alessio
Fama, Rosella
Rasi, Silvia
Monti, Sara
Deambrogi, Clara
De Paoli, Lorenzo
Wang, Jiguang
Gattei, Valter
Guarini, Anna
Foa, Robin
Rabadan, Raul
Gaidano, Gianluca
BLOOD, 2014, 123 (14) : 2139 - 2147
[43] TP53 MUTATIONS ARE INFREQUENT IN NEWLY-DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA
Murray, F.
Zainuddin, N.
Kanduri, M.
Gunnarsson, R.
Smedby, K. Ekstrom
Enblad, G.
Jurlander, I.
Juliusson, G.
Rosenquist, R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 39 - 39
[44] Clinical Impact Of Small TP53 Mutated Subclones In Chronic Lymphocytic Leukemia
Rossi, Davide
Khiabanian, Hossein
Ciardullo, Carmela
Spina, Valeria
Bruscaggin, Alessio
Fama, Rosella
Monti, Sara
Rasi, Silvia
Wang, Jiguang
Gattei, Valter
Guarini, Anna
FoA, Robin
Rabadan, Raul
Gaidano, Gianluca
BLOOD, 2013, 122 (21)
[45] Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
Brieghel, Christian
Kinalis, Savvas
Yde, Christina W.
Schmidt, Ane Y.
Jonson, Lars
Andersen, Michael A.
da Cunha-Bang, Caspar
Pedersen, Lone B.
Geisler, Christian H.
Nielsen, Finn C.
Niemann, Carsten U.
HAEMATOLOGICA, 2019, 104 (04) : 789 - 796
[46] Ibrutinib for the treatment of chronic lymphocytic leukemia
Deodato, Marina
Frustaci, Anna Maria
Zamprogna, Giulia
Cairoli, Roberto
Montillo, Marco
Tedeschi, Alessandra
EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
[47] Ibrutinib for treatment of chronic lymphocytic leukemia
Vela, Cory M.
McBride, Ali
Jaglowski, Samantha M.
Andritsos, Leslie A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 367 - 375
[48] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
Hua-Jie Dong
Cheng Fang
Li Wang
Lei Fan
Ji Xu
Jia-Zhu Wu
Ting-Xun Lu
Jian-Yong Li
Wei Xu
Medical Oncology, 2014, 31
[49] Ibrutinib for the treatment of chronic lymphocytic leukemia
Farooqui, Mohammed Z. H.
Wiestner, Adrian
EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (11): : 925 - 933
[50] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
Dong, Hua-Jie
Fang, Cheng
Wang, Li
Fan, Lei
Xu, Ji
Wu, Jia-Zhu
Lu, Ting-Xun
Li, Jian-Yong
Xu, Wei
MEDICAL ONCOLOGY, 2014, 31 (04)

← 1 2 3 4 5 →